152 related articles for article (PubMed ID: 22391566)
1. EpCAM regulates cell cycle progression via control of cyclin D1 expression.
Chaves-Pérez A; Mack B; Maetzel D; Kremling H; Eggert C; Harréus U; Gires O
Oncogene; 2013 Jan; 32(5):641-50. PubMed ID: 22391566
[TBL] [Abstract][Full Text] [Related]
2. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation.
Münz M; Kieu C; Mack B; Schmitt B; Zeidler R; Gires O
Oncogene; 2004 Jul; 23(34):5748-58. PubMed ID: 15195135
[TBL] [Abstract][Full Text] [Related]
3. The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation.
Labalette C; Nouët Y; Sobczak-Thepot J; Armengol C; Levillayer F; Gendron MC; Renard CA; Regnault B; Chen J; Buendia MA; Wei Y
J Biol Chem; 2008 May; 283(22):15201-8. PubMed ID: 18378678
[TBL] [Abstract][Full Text] [Related]
4. A novel function of EpCAM in oral squamous cell carcinoma cells under anchorage-independent conditions.
Inoue H; Ohnishi Y; Nakajima M; Kakudo K; Nozaki M
Int J Oncol; 2011 Dec; 39(6):1401-5. PubMed ID: 21785818
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
6. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
[TBL] [Abstract][Full Text] [Related]
7. B-cell receptor-associated protein 31 regulates human embryonic stem cell adhesion, stemness, and survival via control of epithelial cell adhesion molecule.
Kim WT; Seo Choi H; Min Lee H; Jang YJ; Ryu CJ
Stem Cells; 2014 Oct; 32(10):2626-41. PubMed ID: 24898727
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
Srethapakdi M; Liu F; Tavorath R; Rosen N
Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
[TBL] [Abstract][Full Text] [Related]
9. Nuclear signalling by tumour-associated antigen EpCAM.
Maetzel D; Denzel S; Mack B; Canis M; Went P; Benk M; Kieu C; Papior P; Baeuerle PA; Munz M; Gires O
Nat Cell Biol; 2009 Feb; 11(2):162-71. PubMed ID: 19136966
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
[TBL] [Abstract][Full Text] [Related]
11. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
12. Myostatin inhibits rhabdomyosarcoma cell proliferation through an Rb-independent pathway.
Langley B; Thomas M; McFarlane C; Gilmour S; Sharma M; Kambadur R
Oncogene; 2004 Jan; 23(2):524-34. PubMed ID: 14724580
[TBL] [Abstract][Full Text] [Related]
13. The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways.
Labalette C; Nouët Y; Levillayer F; Armengol C; Renard CA; Soubigou G; Xia T; Buendia MA; Wei Y
PLoS One; 2008; 3(11):e3761. PubMed ID: 19018287
[TBL] [Abstract][Full Text] [Related]
14. Gankyrin promotes the proliferation of human pancreatic cancer.
Meng Y; He L; Guo X; Tang S; Zhao X; Du R; Jin J; Bi Q; Li H; Nie Y; Liu J; Fan D
Cancer Lett; 2010 Nov; 297(1):9-17. PubMed ID: 20483533
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
Khwaja F; Djakiew D
Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
[TBL] [Abstract][Full Text] [Related]
16. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
Tenderenda M
J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
[TBL] [Abstract][Full Text] [Related]
17. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
Qi Y; Tu Y; Yang D; Chen Q; Xiao J; Chen Y; Fu J; Xiao X; Zhou Z
J Cell Physiol; 2007 Jan; 210(1):63-71. PubMed ID: 17013808
[TBL] [Abstract][Full Text] [Related]
18. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
[TBL] [Abstract][Full Text] [Related]
19. Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer.
Liao MY; Kuo MY; Lu TY; Wang YP; Wu HC
Int J Oncol; 2015 Apr; 46(4):1788-800. PubMed ID: 25652097
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
